Aprogen Pharmaceuticals Inc (003060) — Capital Reinvestment Ratio
Aprogen Pharmaceuticals Inc (003060) has a Capital Reinvestment Ratio of 0.87x as of December 2022, meaning it reinvests 1% of its operating cash flow (₩676.93 Million) in capital expenditures (₩591.03 Million). See Aprogen Pharmaceuticals Inc (003060) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Aprogen Pharmaceuticals Inc Capital Reinvestment Ratio (2010–2022)
This chart tracks Aprogen Pharmaceuticals Inc's Capital Reinvestment Ratio across 7 annual periods.
Annual Capital Reinvestment Ratio for Aprogen Pharmaceuticals Inc (2010–2022)
Year-by-year Capital Reinvestment Ratio for Aprogen Pharmaceuticals Inc from 2010 to 2022. For live market cap and broader valuation context, see market value of Aprogen Pharmaceuticals Inc.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.06x | ₩25.73 Billion | ₩1.55 Billion | ▼ -50.2% |
| 2020 | 0.12x | ₩8.09 Billion | ₩976.29 Million | ▼ -96.0% |
| 2019 | 2.98x | ₩713.73 Million | ₩2.13 Billion | ▲ +292.2% |
| 2018 | 0.76x | ₩1.33 Billion | ₩1.01 Billion | ▼ -87.9% |
| 2016 | 6.27x | ₩449.98 Million | ₩2.82 Billion | ▲ +115.6% |
| 2015 | 2.91x | ₩1.85 Billion | ₩5.37 Billion | ▼ -94.1% |
| 2010 | 49.52x | ₩247.92 Million | ₩12.28 Billion | — |